IL4R and lymphoma: These results demonstrated that bispecific antibodies targeting CD20 and either CD74 or IL4R could mediate direct cytotoxicity of lymphoma cells, but when using a rituximab resistant lymphoma cell line (SU-DHL-8), bispecific anti-CD20/anti-CD74 or anti-CD74 alone induced the highest levels of apoptosis.